Next-generation sequencing (NGS) has evolved rapidly over the last decade, and as a result, has revolutionised genomic research. In particular, the COVID-19 pandemic propelled genomics and DNA sequencing into the spotlight. Therefore, the latest edition of our Sequencing Buyer’s Guide, which is available to download for free, could not be more relevant right now.
We would like to give a special thank you to our contributors for their help and guidance in compiling this report :
Adam Ameur, Associate Professor, SciLifeLabNational Genomics Infrastructure, Uppsala University
Andrew Beggs, Academic & Scientific Lead for Genomics, Birmingham Health Partners
Darren Griffin, Professor of Genetics, University of Kent
David Baker, Head of Sequencing, Quadram Institute
David Smith, Professor Emeritus, Mayo Clinic
Eddy de Boer, Researcher and PhD Student, University Medical Center Groningen
Floriana Manodoro, Higher Scientific Officer, Institute of Cancer Research
Leah Catchpole, Genomics Pipeline Team Leader, Earlham Institute
Luciano Martelotto, Head of the Single Cell and Spatial Omics Laboratory, Australian Center for Epigenetics, South Australian ImmunoGenomics Cancer Centre
Luis Zapata Ortiz, Institute of Cancer Research Fellow, Institute of Cancer Research
Miten Jain, Assistant Research Scientist,University of California, Santa Cruz
Natalie Thorne, Innovation and Technology Lead, Melbourne Genomics Health Alliance
Tamas Korcsmaros, Senior Lecturer, Imperial College London
Tara Paton, Service Manager for Genotyping, Sanger and Next Generation Sequencing, The Centre for Applied Genomics
Tatiana Borodina, NGS Unit Team Leader, Max Delbrück Center for Molecular Medicine
Tiffany Boughtwood, Managing Director, Australian Genomics
William Scott, Wellcome Trust Clinical Research Career Development Fellow and Honorary Consultant in Endocrinology and Diabetes, Imperial College London
Chapter 2: What sequencing technologies are available?
Chapter 3: How to choose the right sequencing technology
Chapter 4: Could Out-Sourcing NGS be a better option?
Chapter 5: Single-Cell and spatial sequencing
Chapter 6: Innovation in the sequencing space
Chapter 7: Dealing with NGS data
Chapter 8: Making NGS accessible
Chapter 9: ESG in Genomics
Chapter 10: Planning for shifts in the NGS market
Chapter 11: What does the future of NGS hold?
We are convinced that this new, intelligence-driven format will provide you with unrivalled insights into various aspects of the NGS space. Find out for yourself by downloading the Sequencing Buyer’s Guide here
.png?upscale=true&width=1200&upscale=true&name=Sequencing%20Buyer%E2%80%99s%20Guide%20Report%202022%20-%204th%20Edition%20(2).png)